Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Unity Biotechnology, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.40 | -$0.40 | -$0.40 |
| Q2 2025 | 2 | -$0.32 | -$0.15 | -$0.24 |
| Q3 2025 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q4 2025 | 1 | -$0.25 | -$0.25 | -$0.25 |
Unity Biotechnology, Inc. Earnings Date And Information
Unity Biotechnology, Inc. last posted its earnings results on Tuesday, April 22nd, 2025. The company reported $-0.43 earnings per share for the quarter, missing analysts' consensus estimates of $-0.43 by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Unity Biotechnology, Inc. has generated $-2 earnings per share over the last year ($-1.54 diluted earnings per share) and currently has a price-to-earnings ratio of -0.69. Unity Biotechnology, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 5th, 2025 based on prior year's report dates.
Unity Biotechnology, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/22/2025 | Q1 2025 | -$0.43 | -$0.43 | 0 | $0 | $0 |
| 04/11/2025 | Q4 2024 | N/A | -$0.51 | N/A | $0 | $0 |
| 11/04/2024 | Q3 2024 | -$0.40 | -$0.38 | 0.02 | $0 | $0 |
| 08/06/2024 | Q2 2024 | -$0.44 | -$0.31 | 0.13 | $0 | $0 |
| 05/14/2024 | Q1 2024 | N/A | -$0.34 | N/A | N/A | $0 |
| 04/15/2024 | Q4 2023 | -$0.48 | $0.00 | N/A | N/A | $1.90 M |
| 11/13/2023 | Q3 2023 | -$0.87 | -$1.01 | -0.14 | N/A | $0 |
| 08/08/2023 | Q2 2023 | -$0.83 | -$1.07 | -0.24 | N/A | $0 |
| 05/09/2023 | Q1 2023 | -$1.10 | -$0.37 | 0.73 | N/A | $0 |
| 03/15/2023 | Q4 2022 | -$1.15 | -$1.00 | 0.15 | N/A | $-236,000 |
| 11/08/2022 | Q3 2022 | -$0.99 | -$1.36 | -0.37 | N/A | $0 |
| 08/12/2022 | Q2 2022 | -$2.80 | -$1.90 | 0.9 | N/A | $236.00 K |
| 05/10/2022 | Q1 2022 | -$2.60 | -$2.80 | -0.2 | N/A | $0 |
| 03/15/2022 | Q4 2021 | -$3.10 | -$1.80 | 1.3 | N/A | $4.78 M |
| 11/10/2021 | Q3 2021 | -$3.80 | -$2.97 | 0.83 | N/A | $0 |
| 08/10/2021 | Q2 2021 | -$3.20 | -$3.20 | 0 | N/A | $0 |
| 05/11/2021 | Q1 2021 | -$3.80 | -$2.90 | 0.9 | N/A | $0 |
| 03/23/2021 | Q4 2020 | -$3.80 | -$3.70 | 0.1 | N/A | $0 |
| 11/04/2020 | Q3 2020 | -$4.50 | -$5.20 | -0.7 | N/A | $0 |
| 07/31/2020 | Q2 2020 | -$5.10 | -$3.80 | 1.3 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Unity Biotechnology, Inc. Earnings: FAQ's
Unity Biotechnology, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 5th, 2025 based offlast year's report dates.
The conference call for Unity Biotechnology, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Unity Biotechnology, Inc.'s latest earnings report can be read online.
Unity Biotechnology, Inc. (:UBX) has a recorded net income of $-25,990,000.Unity Biotechnology, Inc. has generated $-1.54 earnings per share over the last four quarters.
Unity Biotechnology, Inc. (:UBX) has a price-to-earnings ratio of -0.69 and price/earnings-to-growth ratio is 0.12.